National Bank of Canada
WST icon

National Bank of Canada’s West Pharmaceutical WST Stock Holding History

National Bank of Canada’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4M Buy
49,636
+1,896
+4% +$472K 0.01% 636
2025
Q4 		$13.1M Buy
47,740
+2,437
+5% +$667K 0.01% 644
2025
Q3 		$11.9M Sell
45,303
-5,623
-11% -$1.37M 0.01% 646
2025
Q2 		$11.1M Sell
50,926
-4,378
-8% -$936K 0.01% 753
2025
Q1 		$12.4M Buy
55,304
+20,805
+60% +$5.73M 0.01% 657
2024
Q4 		$11.3M Sell
34,499
-2,772
-7% -$872K 0.01% 731
2024
Q3 		$11.2M Buy
37,271
+3,012
+9% +$922K 0.01% 639
2024
Q2 		$11.1M Buy
34,259
+2,828
+9% +$999K 0.02% 535
2024
Q1 		$11.4M Sell
31,431
-10,426
-25% -$3.86M 0.02% 581
2023
Q4 		$14.5M Sell
41,857
-10,727
-20% -$3.8M 0.02% 485
2023
Q3 		$19.6M Buy
52,584
+17,396
+49% +$6.73M 0.03% 426
2023
Q2 		$13.2M Buy
35,188
+30,067
+587% +$10.7M 0.02% 482
2023
Q1 		$1.77M Buy
5,121
+911
+22% +$266K ﹤0.01% 891
2022
Q4 		$991K Buy
4,210
+1,485
+54% +$352K ﹤0.01% 1085
2022
Q3 		$694K Buy
2,725
+162
+6% +$49.4K ﹤0.01% 1086
2022
Q2 		$787K Sell
2,563
-3,075
-55% -$1M ﹤0.01% 1085
2022
Q1 		$2.23M Sell
5,638
-17,745
-76% -$6.95M 0.01% 843
2021
Q4 		$10.9M Buy
+23,383
New +$10.1M 0.04% 371

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

National Bank of Canada's WST Position: Q1 2026 in Review

National Bank of Canada increased its West Pharmaceutical (WST) stake by 4% in Q1 2026, buying an estimated $472K and bringing the position to 49,636 shares worth $12.4M. The position accounts for 0.01% of the portfolio, ranked #636.

National Bank of Canada first reported a position in WST in Q4 2021 and has held it in 18 quarters since. The position peaked at $19.6M in Q3 2023. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • National Bank of Canada held 49,636 shares of West Pharmaceutical worth $12.4M as of Q1 2026.
  • National Bank of Canada bought 1,896 West Pharmaceutical shares in Q1 2026, an estimated $472K.
  • West Pharmaceutical made up 0.01% of National Bank of Canada's portfolio in Q1 2026, its #636 holding.
  • National Bank of Canada first reported a position in West Pharmaceutical in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's West Pharmaceutical position peaked at $19.6M in Q3 2023.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.